CARDIAC INVOLVEMENT IN ALAGILLE SYNDROME

View at publisher Summarise with VIRAT
Authors: Yagmur Damla Onal
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Alagille syndrome (AGS) is a rare autosomal dominant multisystem disorder characterized by hepatic, cardiac, vascular, skeletal, renal, ocular, and craniofacial anomalies, with an estimated incidence of 1 in 100,000 live births. Pathogenic variants in JAG1 or NOTCH2, which disrupt the Notch signaling pathway, underlie the disease, though genotype-phenotype correlations are limited and expressivity remains highly variable. Clinically, diagnosis relies on the recognition of bile duct paucity and major features including cholestasis, peripheral pulmonary artery stenosis, skeletal or ocular anomalies, and typical facial features, with molecular genetic confirmation providing further diagnostic precision.Cardiac involvement represents a critical determinant of morbidity and mortality, being reported in up to 90% of patients. Peripheral pulmonary artery stenosis (PAS) is the most common cardiovascular lesion, occurring in nearly three-quarters of cases, followed by complex defects such as tetralogy of Fallot and pulmonary atresia, which significantly worsen prognosis. Rare but clinically important associations, such as mid-aortic syndrome and parachute mitral valve, further expand the cardiovascular spectrum. Vasculopathy is increasingly recognized as a primary pathogenic mechanism, contributing not only to congenital heart disease but also to noncardiac vascular anomalies, including intracranial aneurysms and renovascular lesions.Management requires careful stratification according to severity and transplant candidacy. Catheter-based approaches, including balloon angioplasty and stent implantation, are generally preferred over surgery due to lower invasiveness and comparable long-term outcomes, though restenosis remains frequent. Optimization of right ventricular and pulmonary artery pressures is essential before liver transplantation, as uncontrolled pulmonary hypertension significantly increases perioperative mortality. Hepatic dysfunction also strongly impacts outcomes of cardiac surgery, with higher Model for End-Stage Liver Disease (MELD) scores correlating with a four-fold increase in mortality. These findings underscore the importance of integrating hepatic and cardiac assessment into treatment planning.Given the multisystem nature of AGS, multidisciplinary care is indispensable. Close collaboration among hepatologists, cardiologists, geneticists, transplant surgeons, and allied specialists ensures timely recognition of complications, appropriate intervention, and optimized long-term outcomes. Despite advances in diagnostic imaging, interventional cardiology, and transplantation, cardiac involvement remains one of the strongest predictors of survival in AGS. Continued progress will depend on refining therapeutic strategies, improving risk stratification, and strengthening multidisciplinary models of care.Keywords: Alagille syndrome; Pulmonary artery stenosis

Fields of Study & Subjects

Pediatric Hepatobiliary Diseases and Treatments Congenital Heart Disease Studies Congenital heart defects research

Publication details

Journal / source
Turkiye Klinikleri eBooks
Pages
227–236
Publication date
1 January 2026
Language
EN
Document type
Book chapter